VITL

Vital Farms, Inc. (VITL) - 10-K Summary

Business Context and Reporting Period

Company: Vital Farms, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 28, 2025 (52 weeks)
Business Overview: Vital Farms is a leading producer of pasture-raised eggs and butter, operating through a network of over 600 family farms and company-owned "accelerator farms." The company is a Certified B Corporation and a Delaware public benefit corporation. Its primary processing facility, Egg Central Station, is located in Springfield, Missouri. The company is currently constructing a second facility, Vital Crossroads, in Seymour, Indiana, expected to be operational in 2027.

Key Financial Metrics

Note: The company has a $60.0 million revolving credit facility with JPMorgan Chase, of which $0 was drawn as of December 28, 2025.

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased by $153.1 million (25%), driven by volume growth of $78.3 million and price/mix benefits of $74.9 million. Retail channel revenue accounted for the majority of sales.
• Operating Expenses: Selling, General, and Administrative (SG&A) expenses rose 19% to $159.4 million, primarily due to increased employee-related costs ($10.4 million), marketing expenses ($10.3 million), and technology costs related to a new ERP system ($3.8 million).
• Inventory Build: Inventory levels increased significantly from $23.7 million to $66.5 million, reflecting a $47.8 million cash outflow for inventory purchases to support growth and new facility preparations.
• Cash Flow: Net cash provided by operating activities decreased to $33.7 million from $64.8 million, largely due to the increase in inventory purchases and operating lease payments. Net cash used in investing activities increased to $134.3 million, driven by purchases of property, plant, and equipment ($82.0 million) and available-for-sale securities ($95.1 million).
• Internal Controls: The company remediated a material weakness in internal control over financial reporting identified in the prior year, specifically regarding revenue process controls, effective as of December 28, 2025.

Guidance, Outlook, and Risks

Outlook and Strategy:

• Expansion: Construction is underway for the Vital Crossroads facility in Indiana, with anticipated capital expenditures of $120.0 million to $140.0 million over the next 12 months.
• Accelerator Farms: The company began placing birds on company-owned accelerator farms in 2025 to test innovative practices and ensure supply chain resilience.
• Stock Repurchase: On February 19, 2026, the Board authorized a $100.0 million stock repurchase program through February 2028.
• Leadership Change: Founder Matthew O'Hayer resigned as Executive Chairperson and Board member in February 2026; Russell Diez-Canseco (CEO) was appointed Executive Chairperson.

Key Risks and Contingencies:

• Agricultural Disease: Outbreaks of Highly Pathogenic Avian Influenza (HPAI) and Egg Drop Syndrome (EDS) pose significant supply risks. While no HPAI outbreaks occurred on company farms in 2025, 12 farms experienced EDS outbreaks.
• Supply Chain Concentration: A substantial amount of processing occurs at a single facility (Egg Central Station). Disruption there would significantly impact operations.
• Commodity and Input Costs: Fluctuations in feed grain prices (corn, soy) and packaging costs impact margins. The company uses derivative instruments to hedge commodity risk.
• Trade and Tariffs: The company imports butter from Ireland and packaging materials. Recent changes in U.S. tariff policies create uncertainty regarding costs and supply chain availability.
• Customer Concentration: A limited number of distributors and retailers represent a significant portion of sales. UNFI accounted for 22% of net revenue in 2025, and Whole Foods accounted for approximately 20% of retail sales.

Investor Verification Checklist

• Inventory Valuation: Verify the rationale and obsolescence reserves for the significant increase in inventory ($66.5 million) relative to sales velocity.
• Capital Expenditure Execution: Monitor progress and cost overruns on the Vital Crossroads facility and accelerator farm development.
• Disease Impact: Track the frequency and severity of EDS and HPAI outbreaks within the farm network and their impact on supply availability.
• ERP System Stability: Assess the long-term operational efficiency gains from the new cloud-based ERP system implemented in late 2025.
• Margin Sustainability: Evaluate the ability to maintain 38% gross margins amidst rising labor, feed, and packaging costs and potential tariff impacts.